Prado-Mel E - Search Results

1

Association between Anticholinergic Burden and Constipation: A Systematic Review.

Rodríguez-Ramallo H, Báez-Gutiérrez N, Prado-Mel E, Alfaro-Lara ER, Santos-Ramos B, Sánchez-Fidalgo S. Rodríguez-Ramallo H, et al. Among authors: prado mel e. Healthcare (Basel). 2021 May 13;9(5):581. doi: 10.3390/healthcare9050581. Healthcare (Basel). 2021. PMID: 34068348 Free PMC article. Review.

2

[Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].

Alfaro-Lara ER, Galván-Banqueri M, Prado-Mel E, Santos-Ramos B, Varela-Aguilar JM, Torelló-Iserte J, Castellano Zurera MM, Bautista Paloma FJ. Alfaro-Lara ER, et al. Farm Hosp. 2010 Mar-Apr;34(2):76-84. doi: 10.1016/j.farma.2009.09.004. Epub 2010 Jan 25. Farm Hosp. 2010. PMID: 20304366 Free article. Spanish.

3

[Failure mode effect analysis for safety improvement in the automatic drug dispensing systems].

Prado-Mel E, Mejías Trueba M, Reyes González I, Gallego Espina MA, Martín Márquez MT, Alfaro Lara ER. Prado-Mel E, et al. J Healthc Qual Res. 2021 Mar-Apr;36(2):81-90. doi: 10.1016/j.jhqr.2020.08.003. Epub 2021 Jan 22. J Healthc Qual Res. 2021. PMID: 33495116 Spanish.

4

Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review.

Prado-Mel E, Ciudad-Gutiérrez P, Rodríguez-Ramallo H, Sánchez-Fidalgo S, Santos-Ramos B, Villalba-Moreno AM. Prado-Mel E, et al. BMC Pharmacol Toxicol. 2022 Dec 21;23(1):94. doi: 10.1186/s40360-022-00637-8. BMC Pharmacol Toxicol. 2022. PMID: 36539885 Free PMC article.

5

Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.

Jiménez Galán R, Prado-Mel E, Pérez-Moreno MA, Caballano-Infantes E, Flores Moreno S. Jiménez Galán R, et al. Among authors: prado mel e. Biology (Basel). 2021 Sep 9;10(9):890. doi: 10.3390/biology10090890. Biology (Basel). 2021. PMID: 34571767 Free PMC article.

6

Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer.

Jiménez Galán R, Prado-Mel E, Alvarez de Sotomayor M, Martin LA. Jiménez Galán R, et al. Among authors: prado mel e. Biology (Basel). 2023 Jan 26;12(2):191. doi: 10.3390/biology12020191. Biology (Basel). 2023. PMID: 36829469 Free PMC article.

7

[Mesalazine-induced intersticial pneumonitis in patients with ulcerative colitis].

Prado Mel E, Gil López M. Prado Mel E, et al. Farm Hosp. 2016 Jan 1;40(1):55-7. doi: 10.7399/fh.2016.40.1.10220. Farm Hosp. 2016. PMID: 26882835 Spanish. No abstract available.

8

[Staphylococcus warneri and Staphylococcus lugdunensis bacteriemia after handling intrauterine device].

Prado Mel E, Gil López M, Rojas Ramírez AB. Prado Mel E, et al. Med Clin (Barc). 2016 Aug 19;147(4):e21. doi: 10.1016/j.medcli.2016.03.027. Epub 2016 Jul 7. Med Clin (Barc). 2016. PMID: 27210807 Spanish. No abstract available.

9

Alectinib - induced acute renal failure.

Prado-Mel E, Ciudad-Gutiérrez P, Sánchez-Martín A, Martín LA. Prado-Mel E, et al. J Oncol Pharm Pract. 2023 Apr 6:10781552231167808. doi: 10.1177/10781552231167808. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37021408

10

Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study.

Carrión-Madroñal IM, Díaz-Acedo R, Lora-Escobar SJ, Naranjo-Llamas E, Jaramillo-Ruiz D, Artacho-Criado S, Prado-Mel E. Carrión-Madroñal IM, et al. Among authors: prado mel e. Future Oncol. 2024;20(33):2565-2572. doi: 10.1080/14796694.2024.2394408. Epub 2024 Sep 12. Future Oncol. 2024. PMID: 39263951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters